Intellinetics Stock Forecast, Price & News

Intellinetics (OTCMKTS:INLX) Frequently Asked Questions

How has Intellinetics' stock been impacted by COVID-19?

Intellinetics' stock was trading at $0.08 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, INLX shares have increased by 9,962.5% and is now trading at $8.05.
View which stocks have been most impacted by COVID-19.

Are investors shorting Intellinetics?

Intellinetics saw a drop in short interest in the month of October. As of October 29th, there was short interest totaling 100 shares, a drop of 90.0% from the October 14th total of 1,000 shares. Based on an average daily volume of 3,900 shares, the days-to-cover ratio is currently 0.0 days.
View Intellinetics' Short Interest.

How were Intellinetics' earnings last quarter?

Intellinetics, Inc. (OTCMKTS:INLX) released its quarterly earnings data on Monday, November, 15th. The company reported $0.10 earnings per share for the quarter, topping analysts' consensus estimates of $0.01 by $0.09. Intellinetics had a negative net margin of 0.84% and a positive trailing twelve-month return on equity of 33.63%.
View Intellinetics' earnings history.

Who are Intellinetics' key executives?

Intellinetics' management team includes the following people:

• James F. DeSocio, President, Chief Executive Officer & Director
• Mike Beck, Vice President-Operations
• Joe Spain, Chief Financial Officer & Treasurer
• Matt Chretien, Secretary, Director, CTO & Chief Strategy Officer
• Thomas D. Moss, Vice President-Research & Development

Who are some of Intellinetics' key competitors?

Some companies that are related to Intellinetics include AudioEye (AEYE), Elys Game Technology (ELYS), Mobivity (MFON), Rego Payment Architectures (RPMT), BTCS (BTCS), Aware (AWRE), CLPS Incorporation (CLPS), Great Elm Group (GEG), NetSol Technologies (NTWK), Astea International (ATEA), Information Analysis (IAIC), Datasea (DTSS), Infobird (IFBD), Qumu (QUMU) and Cyren (CYRN).
View all of INLX's competitors.

What other stocks do shareholders of Intellinetics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intellinetics investors own include Co-Diagnostics (CODX), Tonix Pharmaceuticals (TNXP), Inovio Pharmaceuticals (INO), Kopin (KOPN), Onconova Therapeutics (ONTX), OPKO Health (OPK), Precipio (PRPO), Selecta Biosciences (SELB), Sierra Oncology (SRRA) and T2 Biosystems (TTOO).

What is Intellinetics' stock symbol?

Intellinetics trades on the OTCMKTS under the ticker symbol "INLX."

How do I buy shares of Intellinetics?

Shares of INLX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Intellinetics' stock price today?

One share of INLX stock can currently be purchased for approximately $8.05.

How much money does Intellinetics make?

Intellinetics has a market capitalization of $22.73 million and generates $8.25 million in revenue each year. The company earns $-2.20 million in net income (profit) each year or ($0.08) on an earnings per share basis.

How many employees does Intellinetics have?

Intellinetics employs 94 workers across the globe.

What is Intellinetics' official website?

The official website for Intellinetics is www.intellinetics.com.

Where are Intellinetics' headquarters?

Intellinetics is headquartered at 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228.

How can I contact Intellinetics?

Intellinetics' mailing address is 2190 DIVIDEND DRIVE, COLUMBUS OH, 43228. The company can be reached via phone at (614) 921-8170 or via email at [email protected].